Carolina Medicaid). Patients: Those patients with schizophrenia who received initial prescriptions for risperidone (n = 862 … significantly greater in the risperidone [751 US dollars ($US)] and clozapine ($US1423) groups than in the haloperidol group ($US6 … clozapine group was significantly higher ($US2500.23; p < 0.0001 for clozapine vs risperidone and clozapine vs haloperidol). As …

violent episodes decreased with clozapine. Risperidone represents a new class of novel antipsychotics which, like clozapine … Administration (FDA) of clozapine in 1989, no new antipsychotics had been introduced in the US for at least 10 years. Clozapine was … associated with schizophrenia were also shown to improve with clozapine. However, because of the problem of agranulocytosis and …

risperidone in preference to conventional antipsychotics in patients with chronic schizophrenia has been supported by several …The availability of new atypical antipsychotics, such as risperidone, that have higher acquisition costs than … superior efficacy to haloperidol and similar efficacy to other atypical antipsychotics. At dosages <=8 mg/day, risperidone is …

olanzapine and risperidone were studied in three. Clozapine emerged as the SGA with at least some effect on work status. However …Schizophrenia is a serious mental illness that imposes a considerable burden not only on those who are ill, but also on … their families, neighbours and the wider society. Costs associated with treating people with schizophrenia are those derived …

other antipsychotics (risperidone, quetiapine, amisulpride, clozapine and oral or depot typical antipsychotics). Results: A … olanzapine with clozapine and typical depot antipsychotics should be viewed with caution because clozapine is a second … antipsychotics in a naturalistic outpatient setting. Methods: The pan-European SOHO study is a 3-year, prospective, outpatient …

the atypical agent risperidone. Olanzapine may be superior to haloperidol in some respects, including treatment of … at least the same extent as risperidone. However, olanzapine has a high acquisition cost compared with conventional … antipsychotics. Despite this, most pharmacoeconomic analyses indicate that treatment with olanzapine does not significantly increase …

schizophrenia who were initiated on olanzapine or risperidone between 1 January 1997 and 31 August 1998. Each patient was followed … patients who received olanzapine versus risperidone. Multivariate analysis revealed no significant differences in schizophrenia …Objective: To examine both schizophrenia-related costs and total (schizophrenia plus non-schizophrenia) healthcare …

Objective: To compare the clinical and economic outcomes associated with olanzapine and risperidone treatment for … schizophrenia. Design and setting: An international, multicentre, double-blind, prospective study. To facilitate economic … mental disorders, 4th edition (DSM-IV) diagnosis of schizophrenia, schizoaffective disorder or schizophreniform disorder were …

as a long-acting injectable formulation. In patients with schizophrenia, long-acting injectable risperidone (25-50mg … symptomatically stable schizophrenia. Pharmacoeconomic models have indicated that long-acting injectable risperidone - relative to …Schizophrenia is a chronic disease that typically manifests during adolescence and early adulthood. Treatment of this …

As a consequence of its prevalence, early onset and chronicity, schizophrenia imposes clinical and economic impediments … to healthcare practitioners and society alike. Among the many antipsychotics available to treat the symptoms of this … devastating illness, clozapine has emerged and differentiated itself from the others as the agent most efficacious for the …